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  Abstract 
 
Introduction12 
Urinary tract infection (UTI) is the second common 
infection in human which affects millions of people each 
year (1). Increasing rates of resistance among bacterial 
uropathogens has caused growing concern in both 
developed and developing countries. Escherichia coli, 
the most common member of the family 
Enterobacteriaceae, accounts for 75-90% of all UTIs in 
both in- and out-patient settings (2).  
Understanding molecular mechanisms, through which 
resistance genes transfer, may contribute to developing 
new antimicrobial agents as well as preventive measures 
to stop further dissemination of resistance determinants 
among pathogens (3). 
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Many resistance genes in bacterial genomes and in extra-
chromosomal pieces of DNA encode different 
mechanisms of drug resistance (4). Gene mutations can 
spread from cell to cell by mobile genetic elements such  
as transposons and integrons (5). Drug resistance genes 
can easily be transferred among isolates. Plasmids may 
affect bacterial virulence and antibiotic resistance and 
serve as epidemiological markers (5).   
Class 1 integrons are genetic elements located on 
bacterial chromosome or plasmid while transposons 
often carry genetic determinants for antimicrobial drug 
resistance (6).  
Dissemination of antibiotic resistance genes by 
horizontal transfer has led to rapid emergence of 
antibiotic resistance among clinical isolates of bacteria 
(7).  Class 1 integrons are widely distributed among both 
nosocomial and community gram-negative isolates. The 
need for systematic epidemiologic studies on the role of 
class 1 integron in antimicrobial drug resistance in 
bacteria has recently been emphasized. The prevalence 
of class 1 integrons is high among gram-negative isolates 
in European patients (8, 9) and some bacteria carry 
multiple integrons. 
To date, most of the resistance integrons found in clinical 
isolates of Enterobacteriaceae are of class 1 integrons, 
which are highly associated with resistance to 
antimicrobial agents (7). These reports suggest that class 
1 integrons are relatively common, especially among 
Enterobacteriaceae, and they contribute to dissemination 
of antimicrobial drug resistance in healthcare settings. 
Integron structure contains essential elements for 
insertion and mobilization of gene cassette (7).  
Background: Recent studies demonstrated an increased pattern of drug resistance in uropathogenic Escherechia coli 
(E. coli) which is considered as the most common cause of urinary tract infections (UTIs). Present investigation was 
undertaken to evaluate antibiotic resistance pattern of E. coli causing UTIs obtained from urine samples and their 
relationship with integron class1. Apart from that, special emphasis was given on mediated and transferable antibiotic 
resistance in E. coli as well as the mobilized integrons that contribute to dissemination of antibiotic resistance. 
Methods and Materials: Susceptibility of isolates to 12 antibiotics was tested by the Kirby -Bauser disk diffusion 
method. The sensitivity was monitored by zone of inhibition according to the clinical and laboratory standard institute 
(CLSI) guidelines. Plasmid DNA from E. coli strains was tested for class 1 integron by PCR.  
Results:  Rate of resistance to the 12 antibiotics is as follows: Ampicillin (89.4%), Cefotaxim (31%), Ciprofloxacin 
(22.4%), Aztreonam (21.7%), Ceftazidim (21.1%), Ceftriaxon (20.5%), Co-trimoxazole (19.9%), Gentamicin (15.5%), 
Amikacin (7.5%), Cefepim (11.8%), Nitrofurantoin (6.2) and Imipenem (1.9%). Existence of integron was confirmed in 
41.9% of isolates. Significant association was evaluated by PCR between resistance to Gentamicin, Amikacin, 
Gentamicin, Amikacin, Cefotaxim, Ceftazidim, Ceftriaxon, Aztreonam, Ciprofloxacin and Co-trimoxazole with the 
existence  of  class 1 integrons.  
Conclusion: Imipenem could be used as the initial therapy for E. coli in UTIs. Similar studies are essential to determine 
appropriate guidelines for empirical therapy which vary by location.  
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In present study, we analyzed the association between 
class1 integron and antibiotic resistance pattern in 
Escherichia coli isolates of urine samples obtained from 
patients referred to our institution. 
 
Methods and materials: 
Total number of 161 Escherichia coli samples were 
obtained from urine specimens of patients at Hajar 
Hospital (affiliated to Shahrekord University of Medical 
Sciences, Shahrekord, Iran) between April and August 
2010 by standard bacteriological methods. The drug 
susceptibility tests were done for all isolates by Kirby-
Bauser agar disk diffusion method as recommended by 
CLSI (10) on Muler-Hinton agar medium (Merck, 
Germany) for antimicrobial disks (Mast Co.) including 
Gentamicin (10µg), Amikacin (30µg) ,Ceftriaxon (10 
µg), Aztreonam (30 µg), Cefepim (20 µg), Ceftazidim 
(30µg), Ampicillin )20 µg),  Imipenem (10 µg) , 
Ciprofloxacin (5 µg), Co-trimoxazole ( 25 µg)  and 
Nitrofurantoin (300 µg) (10). DNA was extracted by 
using of Sinagene DNPTM kit (Sinagene Co, Tehran, 
Iran). Integron Class 1 was detected using PCR targeting 
conserved sequences of class 1 integron (intI1), as 
adapted from Ebner et al (2004). Primer pairs were 
purchased from a commercial source (DNPTM 
Sinagene). Twenty-five µl of reaction mastermix was 
used composed of 2.5 Mm of 10x PCR, 1.5Mm of 50 
Mm MgCl2, 2.5 Mm dNTP, 0.5 Mm of primer (forward 
and reverse) together with 0.1 unit of Taq DNA 
polymerase (5 U/ml) primers (reported from 5´ to 3´) 
comprised Inti1-F';TCTCGGGTAACATCAAAG-
3'andIntI-R:5'-AGGAGATCCGAAGACCTC-3' (11). 
Amplification specification were as follows: 4 min at 94º 
C followed by 30 cycles of 1 min at 94º C, 45 min at 55º 
C ,30s at 72º C and 5 min at 72º C. PCR products were 
analyzed by acrylamid gel electrophoresis.  The expected 
size (241bp) was ascertained by electrophoresis in 
polyacrylamid gel with appropriate molecular size 
markers (100bp DNA ladder). E. coli (ATCC25922) was 
used as a control for determination of antibiotic 
susceptibility and PCR amplification. The analysis of the 
findings was performed by Chi-Square test and 
Statistical Package for Social Sciences (SPSS). P-value 
of ≤0.05 was considered as statistically significant. 
 
Results 
coli isolated from 161 urine samples of patients of which 
72.7% (n = 117) were female and 27.3% (n = 44) were 
male. Rate of resistance to 12 antibiotics was as 
followed; Ampicillin (89.4%), Cefotaxim (31%), 
Ciprofloxacin (22.4%), Aztreonam (21.7%), Ceftazidim 
(21.1%), Ceftriaxon (20.5%), Co-trimoxazole (19.9%), 
Gentamicin (15.5%) Amikacin (7.5%), Cefepim 
(11.8%), Nitrofurantoin (6.2) and Imipenem (1.9%) 
(figure 1). The highest and lowest levels of resistance 
were to Ampicillin and Imipenem, respectively.  
Frequencies of resistance to three, four, five and six or 
more antibiotics were 37 (35.5%), 22 (21.1%), 19 
(18.2%) and 26 (25%), respectively. The existence of 
class 1 integron was confirmed for 79 (49.1%) of isolates 
by PCR (figure 2). Association of drug resistance to 
Amikacin, Gentamicin, Cefotaxim, Ceftazidim, 
Ceftriaxon, Aztreonam, Ciprofloxacin and cotrimoxazole 
with existence of class1 integron was statically 
significant (table 1).  
 
Discussion 
Objective of the present study was to investigate the drug 
resistance pattern and the frequency of class 1 integron 
as well as the relationship between antibiotic resistance 
and class 1 integron of the E. coli isolates in patients 
with UTI. Isolates in this study were highly sensitive to 
Imipenem. Extreme sensitivity of E. coli isolates to 
Imipenem has been earlier reported by Tariq et al (18(. 
Furthermore, this antibiotic has been recently 
administrated in clinical practice.  
Quinolones (ciprofloxacin for instance) are often 
prescribed to treat gastrointestinal infections and UTI. 
Therefore, it could be expected that the prevalence of 
strains resistant to these antibiotics is increasing 
gradually. A consistent stepwise increase in E. coli 
resistance to Ciprofloxacin was observed from 1995 
(0.7%) to 2001 (2.5%) by Bolon et al (19). Ciprofloxacin 
resistance was 25.8% in Portugal and 24.3% in Italy 
while in Germany and the Netherlands it was 15.2% and 
6.8%, respectively (20). Ciprofloxacin resistance in our 
isolates was 21%, which was similar to that in Southern 
European countries.  
Previous studies showed associations between drug 
resistance genes and class 1 integron in bacteria 
responsible for nosocomial outbreaks (21). Class 1 
integrons are frequently reported in clinical isolates of 
Enterobacteriaceae. As reported in other recent studies, 
resistance to Quinolones was more common among 
integrons-containing strains (22). 
To alleviate this suffering situation in developing 
nations, clinicians should prescribe antibiotics wisely 
and sufficiently and there should be periodic 
supervisions on drug consumption by state organizations 
(23). It is worth mentioning that in present study, 64.6% 
of samples were resistant to three or more antibiotics, 
most noticeably to Ampicillin. Different resistance rates 
are from Iran. It was 65% in recent years (23, 25) and 
10.9% in Kashan (26). Varying resistance rates in 
different countries indicates how prescriptions are 
controlled. We found the minimum resistance for 
Imipenem and Amikacin. Tariq, Mathai and Adwan, also 
reported the high sensitivity of Imipenem as the drug of 
choice for UTI )18, 24, 25(. The results of this study 
showed a significant association between overuse of 
antibiotics and the emergence of resistance in E. coli in 
UTI. Widespread use of these agents has contributed to 
the rise of bacterial Quinolone resistance. 
Fluoroquinolones should thus be used prudently while 
avoiding unnecessary prescriptions and considering 
alternative regimens for UTI. The widespread 
dissemination of resistant organisms would severely 
limit therapeutic options for physicians facing these 
organisms, because Carbapenems are the only drugs 
uniformly active against these organisms. The increased 
risk of resistance of E. coli in hospitalized patients 
should be considered as an alarm for choosing alternative 
therapies for community-acquired UTIs. It is important 
that these new antimicrobial agents should be used 
sparingly and with discretion. Furthermore, continuous 
monitoring of the antibiotic susceptibility of 
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Carbapenems is also necessary to check the effectiveness 
of this medication. The results of such study would be 
beneficial for determining guidelines for empirical 
therapy regimens. This is an important consideration 
reflected the fact that inappropriate choice of empirical 
antibiotics has been associated with poor outcomes and 
higher mortality rates in patients infected with E. coli.  
Class 1 integrons play an important role in antibiotic 
resistance of clinical E. coli strains because they are able 
to capture, integrate and express gene cassettes encoding 
certain antibiotic resistance (16). The presence of 
integrons in E. coli isolates is a serious risk factor for 
spreading antimicrobial resistance. The prevalence of 
integrons ranging from 22% to 59% which has been 
reported from clinical E. coli isolates in several previous 
studies on UPEC in Europe and Asia (6, 15). We also 
observed a similar trend of prevalence of class 1 integron 
(49.01%) in our study. In our isolates, class 1 integrons 
were significantly associated with resistance to certain 
antibiotics including Gentamicin, Ceftriaxon, 
Aztreonam, Ciprofloxacin and Co-trimoxazole which is 
comparable with similar studies in south and   northern 
west of Iran (27, 28).  
 Our findings also suggested that urine cultures and 
susceptibility tests cannot be neglected to avoid 
worrisome trend of developing resistance to most 
commonly administered antimicrobials used for 
treatment of UTIs.  
Conclusion 
 
Most of our E. coli isolates showed multiple antibiotic 
resistance. Maximum resistance was found against 
Ampicillin whereas minimum resistance was detected 
against Imipenem. Hence Imipenem might be the drug of  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
choice to treat UTI. The results presented in this study 
could also help the establishment and enforcement of 
infection control measures. 
 
Figure 1. Antibiotic resistance/sensitivity pattern of 
 Escherichia coli isolates (n = 161) recovered from UTI patients 
 
 
 
 
Figure 2: Class 1 integron (int1; 241bp) PCR of Escherichia 
coli Lane1:marker lane( 2,3,5,8,9) intI +) lane13,14 positive, 
negative  control –lane 1-1316sRrNA(479bp) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table1:   Association between integrons and antibiotic resistance in 161 Escherichia coli isolates. 
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